BIOLASE Technology, Inc.
BLTI, announced today that it has received approval from the
Korean Food and Drug Administration to sell its Waterlase
iPlus all-tissue dental laser systems throughout South Korea.
South Korea has an estimated 25,000 dentists and 16,000 dental
clinics, and their progressive dental practitioners have been
particularly prone to adopting high-tech dental equipment, including
more than 1,000 practices that currently use one or more BIOLASE
dental lasers.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in